Featured Research

from universities, journals, and other organizations

For The First Time, Drug Shows Promise To Help Spit Tobacco Users Quit

Date:
September 4, 2002
Source:
Mayo Clinic
Summary:
A Mayo Clinic pilot study shows bupropion, an antidepressant known to help smokers quit, could help spit tobacco users kick the habit too. Study participants were randomly assigned to take either bupropion or a placebo for 12 weeks. At the 12-week mark, 44 percent in the bupropion group were abstinent compared with 26 percent in the placebo group.

ROCHESTER, Minn. -- A Mayo Clinic pilot study shows bupropion, an antidepressant known to help smokers quit, could help spit tobacco users kick the habit too. Study participants were randomly assigned to take either bupropion or a placebo for 12 weeks. At the 12-week mark, 44 percent in the bupropion group were abstinent compared with 26 percent in the placebo group.

Another striking result: Participants who took bupropion gained less weight during the 12 weeks than those who took the placebo -- an average of 1.54 pounds compared with 9.7 pounds.

"The results are good news for spit tobacco users trying to quit," says Lowell Dale, M.D., a Mayo Clinic specialist in nicotine dependence and lead researcher on the study. "None of the other agents that help smokers quit -- patches and gum -- have been shown to be as effective for spit tobacco users. Until now, spit tobacco users haven't had proven tools available to help them stop," he says.

"While the results are promising, more research is needed," says Dr. Dale. The study included 68 participants, too few to be statistically significant.

At a 24-week follow-up, the abstinence rates were the same for both the placebo and bupropion groups, about 29 percent, indicating that spit tobacco users may benefit from taking bupropion longer than 12 weeks.

Results of this pilot study will be published in the August issue of the journal Nicotine and Tobacco Research. The Mayo Nicotine Research Center plans to launch a larger double-blind study on bupropion for spit tobacco users later this year.

"We know that 12 percent to 16 percent of the adolescent male population uses spit tobacco," Dr. Dale notes. "It's becoming a much more significant problem. We really need to find treatment options for these people."


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "For The First Time, Drug Shows Promise To Help Spit Tobacco Users Quit." ScienceDaily. ScienceDaily, 4 September 2002. <www.sciencedaily.com/releases/2002/09/020904073654.htm>.
Mayo Clinic. (2002, September 4). For The First Time, Drug Shows Promise To Help Spit Tobacco Users Quit. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2002/09/020904073654.htm
Mayo Clinic. "For The First Time, Drug Shows Promise To Help Spit Tobacco Users Quit." ScienceDaily. www.sciencedaily.com/releases/2002/09/020904073654.htm (accessed July 28, 2014).

Share This




More Mind & Brain News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com
University Quiz Implies Atheists Are Smarter Than Christians

University Quiz Implies Atheists Are Smarter Than Christians

Newsy (July 25, 2014) An online quiz from a required course at Ohio State is making waves for suggesting atheists are inherently smarter than Christians. Video provided by Newsy
Powered by NewsLook.com
Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins